feed,title,long_url,short_url
Benzinga,New Amivantamab Data from CHRYSALIS Study Show Robust Clinical Activity and Durable Responses in Patients with Metastatic or Unresectable Non-Small Cell Lung Cancer and EGFR Exon 20 Insertion Mutations,https://www.benzinga.com/pressreleases/21/01/n19385911/new-amivantamab-data-from-chrysalis-study-show-robust-clinical-activity-and-durable-responses-in-p,https://j.mp/2Yrh3zz
Benzinga,martinwolf M&A Advisors Acquires IT Exchangenet,https://www.benzinga.com/pressreleases/21/01/n19385906/martinwolf-m-a-advisors-acquires-it-exchangenet,https://j.mp/3owuado
